Prevalence of vascular complications and factors predictive of their development in young adults with type 1 diabetes: Systematic literature review

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  James, Steven ^a   Gallagher, Robyn ^b   Dunbabin, Janet ^c   Perry, Lin ^d  

^a Northeastern Ontario Family Medicine Program   (Canada)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Hypertension; Nephropathy; Predictors; Prevalence; Quantitative epidemiological systematic review; Retinopathy; Type 1 diabetes; Vascular complications; Young adults

Indexed keywords

ADOLESCENT; ADULT; COMPLICATION; DIABETIC ANGIOPATHIES; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PREVALENCE; YOUNG ADULT;

ADOLESCENT; ADULT; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; HUMANS; PREVALENCE; YOUNG ADULT;

EID: 84900027162     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-593     Document Type: Article

References (65)

1. International Diabetes Federation, IDF Diabetes Atlas Brussels: International Diabetes Federation Fifth 2011
2. Australia's national trends in the incidence of Type 1 diabetes in 0-14 year olds, 2000-2006. Catanzariti L, Faulks K, Moon L, Waters A, Flack J, Craig M, Diabet Med 2009 26 6 596 601
3. Long-term mortality in nationwide cohorts of children-onset type 1 diabetes in Japan and Finland. Asao K, Sarti C, Forsen T, Hyttinen V, Nishimura R, Matsushima M, Diabetes Care 2003 26 2037 2042
4. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Orchard T, Forrest K, Kuller L, Diabetes Care 2001 24 1053 1059
5. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999. Soedamah-Muthu S, Fuller J, Mulnier H, Raleigh V, Lawrenson R, Colhoun H, Diabetologia 2006 49 660 666
6. Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes. Results from the Yorkshire register of diabetes in children and young adults. Feltbower RG, Bodansky HJ, Patterson CC, Parslow RC, Stephenson CR, Reynolds C, McKinney PA, Diabetes Care 2008 31 922 926
7. Lipid disorders in diabetes mellitus and current management. Shen G, Curr Pharm Anal 2007 3 17 24
8. Cardiovascular disease in patients who have diabetes. Goldberg RB, Cardiol Clin 2003 21 399 413 vii
9. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N Engl J Med 1993 329 977 986
10. Prevention and early detection of vascular complications of diabetes. Marshall S, Flyvbjerg A, Br Med J 2006 333 475 480
11. Transition from child-centered to adult health care systems for adolescents with chronic conditions: a Position Paper of the Society for Adolescent Medicine. Blum R, Garell D, Hodgman C, Slap G, J Adolesc Health 1993 14 570 576
12. Services doing the best they can: service experiences of young adults with type 1 diabetes mellitus in rural Australia. Perry L, Lowe J, Steinbeck K, Dunbabin J, J Clin Nurs 2012 21 13-14 1955 1963
13. Application of Australian clinical practice management guidelines: the current state of play in a sample of young people living with Type 1 diabetes in the state of New South Wales and the Australian Capital Territory. Hatherly K, Smith L, Overland J, Johnston C, Brown-Singh L, Diabetes Res Clin Pract 2011 93 3 379 384
14. Lost in transition? Access to and uptake of adult health services and outcomes for young people with type 1 diabetes in regional New South Wales. Perry L, Steinbeck K, Dunbabin J, Lowe J, Med J Aust 2010 193 8 444 449
15. A transition care programme which improves diabetes control and reduces hospital admission rates in young adults with Type 1 diabetes aged 15-25 years. Holmes-Walker D, Llewellyn A, Farrell K, Diabet Med 2007 24 764 769
16. Enough of the problem: a review of time for health care transition solutions for young adults with a chronic illness. Rapley P, Davidson P, J Clin Nurs 2010 19 313 323
17. Evaluation of a systems navigator model for transition from pediatric to adult care for young adults with type 1 diabetes. Van Walleghem N, MacDonald C, Dean H, Diabetes Care 2008 31 1529 1530
18. Quality of care for patients with type 2 diabetes mellitus: a long-term comparison of two quality improvements programmes in the Netherlands. Renders C, Valk G, de Sonnaville J, Diabet Med 2003 20 846 852
19. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta regression analysis. Shojania K, Ranjii S, McDonald K, JAMA 2006 296 427 440
20. Provider-patient interaction in diabetes care: effects on patient self-care and outcomes. A systematic review. Van Dam H, Van der Horst F, Van den Bone B, Patient Educ Couns 2003 51 17 28
21. Systematic Reviews. CRD's guidance for undertaking reviews in health care. Centre for Reviews and Dissemination, Centre for Reviews and Dissemination 2008
22. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Moher D, Liberati A, Tetzlaff J, DG A, PLoS Med 2009 6 7 1 6
23. Standards of Medical Care in Diabetes-2013. American Diabetes Association, Diabetes Care 2013 36 1 11 s66
24. Canadian diabetes association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Can J Diabetes 2013 37 Supp 1 1 s212
25. National Institute for Health and Clinical Excellence, Clinical Guideline 15. Type 1 Diabetes: Diagnosis and Management of Type 1 Diabetes in Children, Young People and Adults London: National Institute for Health and Clinical Excellence 2004
26. Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Early Treatment Diabetic Retinopathy Study Research Group, Arch Opthalmology 1985 103 1796 1806
27. How effective are treatments for diabetic retinopathy? Feris FL III, JAMA 1993 269 1290 1291
28. Mobile diabetes eye care: experience in developing countries. Murthy K, Murthy P, Kapur A, Owens D, Diabetes Res Clin Pract 2012 97 343 349
29. Blindness and laser photocoagulation in patients with childhood-onset type 1 diabetes in Japan. Sano H, Nishimura R, Asao K, Matsudaira T, Morimoto A, Agata T, Sjhimizu H, Tajima N, Br J Ophthalmol 2009 93 726 730
30. K/DOQI clinical practice guidelines for chonic kidney disease: evaluation,classification, and stratification. Kidney Disease Outcomes Quality Institute, Am J Kidney Dis 2002 39 2 (Suppl 1) 1 s266
31. Development of proliferative diabetic retinopathy in African-Americans and whites with type 1 diabetes. Arfken C, Reno P, Santiago J, Klein R, Diabetes Care 1998 21 5 792 795
32. The 16-year incidence, progression and regression of diabetic retinopathy in a young population-based Danish cohort with type 1 diabetes mellitus: the Danish cohort of pediatric diabetes 1987 (DCPD1987). Broe R, Rasmussen M, Frydkjaer-Olsen U, Olsen B, Mortensen H, Peto T, Grauslund J, Acta Diabetol 2014 51 413 420
33. 24-hour ambulatory blood pressure and renal disease ih young subjects with type 1 diabetes. Garg S, Chase P, Icaza G, Rothman R, Osberg I, Cavmain J, J Diabetes Complications 1997 11 263 267
34. Service usage and vascular complications in young adults with type 1 diabetes. James S, Perry L, Gallagher R, Lowe J, Dunbabin J, McElduff P, Acharya S, Steinbeck K, BMC Endocr Disord 2014 14 39 1 9
35. Prevalence of retinopathy differs with age at onset of diabetes in a population of patients with Type 1 diabetes. Kullberg C, Abrahamsson M, Arnqvist H, Finnström K, Ludvigsson J, Diabet Med 2002 19 924 931
36. Lower-than-expected prevalence and severity of retinopathy in an incident cohort followed during the First 4-14 years of type 1 diabetes. The Wisconsin Diabetes Registry Study. LeCaire T, Palta M, Zhang H, Allen C, Klein R, D'Alessio D, Am J Epidemiol 2006 164 143 150
37. Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus. Olsen B, Johannesen J, Sjolie A, Borch-Johnsen K, Hougaard P, Thorsteinsson B, Prammings S, Marinelli K, Mortensen H, Diabet Med 1999 16 79 85
38. The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes. Olsen B, Sjolie A, Hougaard P, Johannesen J, Marinelli K, Jacobsen B, Mortensen H, J Diabetes Complications 2004 18 160 164
39. Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes. effect of diabetes duration, A1c, hypertension, dyslipidemia, diabetes onset, and sex. Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P, Holl R, Diabetes Care 2007 30 2523 2528
40. Infant and toddler type 1 diabetes: complications after 20 years duration. Salardi S, Porta M, Maltoni G, Rubbi F, Rovere S, Cerutti F, Iafusco D, Tumini S, Calwin V, Diabetes Care 2012 35 829 833
41. Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes. Cross sectional data from the German diabetes documentation and quality management system (DPV). Schwab K, Doerfer J, Hecker W, Grulich-Henn J, Wiemann D, Kordonnouri O, Beyer P, Holl R, Diabetes Care 2006 29 2 218 225
42. The integrative review: updated methodology. Whittemore R, Knafl K, J Adv Nurs 2005 52 5 546 553
43. Strengthing the reporting of observational studies in epidemiology (STROBE) statement: checklist for cohort, case-control, and cross-sectional studies. STROBE, 2007 available at http://www.strobe-statement.org/fileadmin/Stobe/uploads/checklists/STROBE-checklist-v4-combined.pdf. Accessed 2nd May 2014
44. CONSORT statement: updated guidelines for reporting parallel group randomisation trials. Schulz K, Altman D, Moher D, Ann Intern Med 2010 152 1 7
45. Improving the uptake of screening for diabetic retinopathy. Ng J, Morlet N, Med J Aust 2013 198 2 69 70
46. Colagiuri S, Brnabic A, Gomez M, Fitzgerald B, Buckley A, Colagiuri R, DiabCo$t Australia Type 1: Assessing the Burden of Type 1 Diabetes in Australia Canberra: Diabetes Australia 2009
47. Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes. Role of insulin therapy and glycemic control. Downie E, Craig M, Hing S, Cusumano J, Chan A, Donaghue K, Diabetes Care 2011 34 2368 2373
48. Duration of diabetes and prevalence of diabetic retinopathy: Istanbul Diabetic Retinopathy Study-IDRS results. Karadeniz Z, Yilmaz M, Diabetes Metab Syndr 2007 1 43 48
49. Prevalence of diabetic retinopathy in patients with type 1 diabetes mellitus. Esteves J, Kramer C, De Azevedo M, Stolz A, Roggia M, Larangeira A, Miozza S, Rosa C, Humberto Lambert J, Pecis M, Rodrigues T, Henrique Santos Canani L, Revista de Associacao Medica Brasileira 2009 55 3 268 273
50. Diabetic retinopathy in African Americans with type 1 diabetes: the New Jersey 725. 1. Methodology, population, frequency of retinopathy, and visual impairment. Roy M, Arch Opthalmology 2000 11 1 97 104
51. Renal involvement in type 1 (IDDM) diabetes in Spain. Diamante E, Diabetes Res Clin Pract 1997 38 129 137
52. Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study. Giorgino F, Laviola L, Perin P, Solnica B, Fuller J, Chaturvedi N, Diabetologia 2004 47 1020 1028
53. Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes. Rodrigues T, Henrique Canani L, Viatroski R, Hoffmann L, Esteves J, Gross J, Diabetes Res Clin Pract 2010 87 240 245
54. Changes in the diabetic retinopathy epidemiology after 14 years in a population of Type 1 and 2 diabetic patients after the new diabetes mellitus diagnosis criteria and a more strict control of the patients. Romero-Aroca P, Fernández-Balart J, Baget-Bernaldiz M, Martinez-Salcedo I, Méndez-Marín I, Salvat-Serra M, Buil-Calvo J, J Diabetes Complications 2009 23 229 238
55. Prevalence and relationship between diabetic retinopathy and nephropathy and its risk factors in the North-East of Spain. A population-based study. Romero-Aroca P, Sagarra-Alamo R, Baget-Bernaldiz M, Fernandez-Ballart J, Mendez-Marin I, Ophthalmic Epidemiol 2010 17 4 251 265
56. Changes in cardiovascular risk factors in a type 1 diabetes population: a 3.5-year study. Wallymahmed W, Morgan C, Gill G, Osman-Hicks V, Chamberlain P, MacFarlane I, Pract Diabetes Int 2008 25 6 223 227
57. Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Maahs D, Kinney G, Wadwa P, Snell-Bergeon J, Dabelea D, Hokanson J, Eurlich J, Garg S, Eckel R, Rewers M, Diabetes Care 2005 28 2 301 306
58. Prevalence of hypertension in IDDM patients in the northern Grand Canary Island, according to the WHO/ISH and JNC-V/ADA criteria. De Pablos-Velasco P, Martinez-Martin F, Aguilar J, Diabetes Res Clin Pract 1997 38 13 191 197
59. U.S. Department of Health and Human Services, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 2004
60. The clinical and economic burden of nonadherence with antihypertensive and lipid-lowering therapy in hypertensive patients. Cherry S, Benner J, Hussein M, Tang S, Nichol M, Value Health 2009 12 489 497
61. ASH position paper: adherence and persistance with taking medication to control high blood pressure. Hill M, Miller N, DeGeest S, J Clin Hypertens 2010 12 757 764
62. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Laing S, Swerdlow A, Slater S, Diabetologia 2003 46 760 765
63. Definition, epidemiology and classification of diabetes in children and adolescents. Craig M, Hattersley A, Donaghue K, Pediatr Diabetes 2009 10 Suppl 12 3 12
64. The Wisconsin epidemiologic study of diabetic retinopathy XXII. The twenty-five-year progression of retinopathy in persons with type 1 diabetes. Klein R, Knudtson M, Lee K, Gangnon R, Klein B, Ophthalmology 2008 115 11 1859 1868
65. Factors associated with clinic non-attendance in adults with type 1 diabetes mellitus. Dyer P, Lloyd C, Lancashire R, Bain S, Barnett A, Diabet Med 1998 15 4 339 343